The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders

Assistant settings

journal：Drug Metabolism and Personalized Therapy

Authors：Andrey Alexandrovitch Kibitov; Elena Mikhaylovna Kiryanova; Ludmila Ivanovna Salnikova; Irina Vladimirovna Bure; Alexander Borisovitch Shmukler; Alexander Olegovitch Kibitov

Published date：2023-6-5

DOI：10.1515/dmpt-2022-0143

PDF link：https://www.degruyter.com/document/doi/10.1515/dmpt-2022-0143/xml

Article link：http://dx.doi.org/10.1515/dmpt-2022-0143

Article Source：Walter de Gruyter GmbH。


Remark：

This post has been completed

Completed attachments will be deleted within 24 hours.